secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001770787-21-000048
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics Q3 revenue $125.3M (+74% YoY); FY2021 guidance raised to $490-500M
-------------------------------------------------------------------------------

- Revenue $125.3M, up 74% YoY and 8% QoQ; operating loss $15.9M vs $65.3M loss last year.
- Gross margin flat at 80%; net loss $17.2M vs $65.8M loss Q3 2020.
- Cash $600.4M; began shipping Chromium X instrument.
- FY2021 revenue guidance revised to $490-500M (64-67% growth over FY2020).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078721000048/0001770787-21-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078721000048/txg-20211103.htm
  HTML page:      https://secwatch.observer/filing/0001770787-21-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer